
China approves 4 new drugs, including a global first-in-class medicine
China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. Wednesday, Chinese regulators announced (Chinese) the conditional approval …